The company’s lead cell therapy candidate, OpRegen, has demonstrated efficacy in dry AMD. Lineage Cell Therapeutics is expanding its pipeline to develop a cell therapy for the potential treatment of hearing loss.1 With the expansion, Lineage is adding a third neuronal cell type to its platform. The company has filed for intellectual property covering the composition and […]

An immuno-therapeutic platform technology – essentially a cytokine factory – that eradicates 100% of intraperitoneal tumors has been developed by researchers at Rice University and licensed exclusively to Avenge Bio, Inc. It appears to have the potential to dramatically improve prognosis for ovarian cancer patients. There is a caveat, however. These results have, so far, only been demonstrated in […]

A couple of months ago, Shoreline Biosciences Chairman and CEO Kleanthis Xanthopoulos, Ph.D. told me that the key to securing venture capital is found in your people. Fresh on the heels of securing a $140 million round of financing, he told me, “More than anything else, it’s about the quality of the people you bring […]